Department of Microbiology and Immunology, Microbiome and Disease Tolerance Centre, McGill University, Montreal, QC, Canada.
Mult Scler. 2018 Jan;24(1):53-57. doi: 10.1177/1352458517737391.
The human microbiota is composed of diverse forms of microorganisms that live on or in us and plays a crucial role in the health and development. Commensal species that reside in the intestine particularly influence host physiology at local and systemic levels. Multiple sclerosis (MS) is a debilitating autoimmune disorder of the central nervous system for which there is currently no cure. While the cause of MS is unknown, there is a growing body of evidence suggesting that the microbiota can play both pathogenic and protective roles in disease progression. In this review, we provide a brief overview, based on both animal and clinical studies, of the current understanding by which the microbiota may influence MS and discuss opportunities for therapeutic intervention that may alleviate the symptoms associated with this debilitating neuroimmunological disease.
人体微生物群由生活在我们身上或体内的多种微生物组成,对健康和发育起着至关重要的作用。肠道中存在的共生物种尤其会在局部和全身水平上影响宿主生理机能。多发性硬化症(MS)是一种使人衰弱的中枢神经系统自身免疫性疾病,目前尚无治愈方法。尽管 MS 的病因尚不清楚,但越来越多的证据表明,微生物群在疾病进展中既可以发挥致病作用,也可以发挥保护作用。在这篇综述中,我们根据动物和临床研究提供了一个简要概述,介绍了目前对微生物群如何影响多发性硬化症的理解,并讨论了可能缓解这种使人衰弱的神经免疫性疾病相关症状的治疗干预机会。